{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T18:51:09Z","timestamp":1787079069519,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12231-4","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:42:55Z","timestamp":1766468575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The efficacy and safety of benznidazole in adults with seropositive indeterminate form, Trypanosoma cruzi infection: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4311-4609","authenticated-orcid":false,"given":"Joshua W.","family":"Trowell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-3266","authenticated-orcid":false,"given":"Edward","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6229-8864","authenticated-orcid":false,"given":"Rachel","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-9888","authenticated-orcid":false,"given":"Anwar E.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8743-6007","authenticated-orcid":false,"given":"Barbara J.","family":"Fuhrman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-4403","authenticated-orcid":false,"given":"Patrick W.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"12231_CR1","unstructured":"World Health Organization. Fact sheet: chagas disease. World Health Organization. 2025 [updated April 2, 2025]. https:\/\/www Accessed 27 Aug 2025."},{"key":"12231_CR2","unstructured":"Pan American Health Organization. Neglected infectious diseases in the Americas: success stories and innovation to reach the neediest. Washington, DC: PAHO; 2016."},{"key":"12231_CR3","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3389\/fpubh.2019.00166","volume":"7","author":"KCF Lidani","year":"2019","unstructured":"Lidani KCF, Andrade FA, Bavia L, Damasceno FS, Beltrame MH, Messias-Reason IJ, et al. Chagas disease: from discovery to a worldwide health problem. Front Public Health. 2019;7:166.","journal-title":"Front Public Health"},{"issue":"9","key":"12231_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3201\/eid3109.241700","volume":"31","author":"NL Beatty","year":"2025","unstructured":"Beatty NL, Hamer GL, Moreno-Peniche B, Mayes B, Hamer SA. Chagas disease, an endemic disease in the United States. Emerg Infect Dis. 2025, Sep;31(9):1691\u201397.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"12231_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1678-9199-19-34","volume":"19","author":"PC Pereira","year":"2013","unstructured":"Pereira PC, Navarro EC. Challenges and perspectives of chagas disease: a review. J Venom Anim Toxins Incl Trop Dis. 2013;19(1):34.","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"9","key":"12231_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jacc.2013.05.046","volume":"62","author":"MC Nunes","year":"2013","unstructured":"Nunes MC, Dones W, Morillo CA, Encina JJ, Ribeiro AL. Council on chagas disease of the interamerican society of C. Chagas disease: an overview of clinical and epidemiological aspects. J Am Coll Cardiol. 2013;62(9):767\u201376.","journal-title":"J Am Coll Cardiol"},{"key":"12231_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/B978-0-12-385863-4.00002-2","volume":"75","author":"C Bern","year":"2011","unstructured":"Bern C, Martin DL, Gilman RH. Acute and congenital chagas disease. Adv Parasitol. 2011;75:19\u201347.","journal-title":"Adv Parasitol"},{"key":"12231_CR8","doi-asserted-by":"publisher","first-page":"e02542021","DOI":"10.1590\/0037-8682-0254-2021","volume":"54","author":"AM Hasslocher-Moreno","year":"2021","unstructured":"Hasslocher-Moreno AM, Xavier SS, Saraiva RM, Sousa AS. Indeterminate form of chagas disease: historical, conceptual, clinical, and prognostic aspects. Rev Soc Bras Med Trop. 2021;54:e02542021.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"12231_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","volume":"33","author":"LE Echeverria","year":"2019","unstructured":"Echeverria LE, Morillo CA. American trypanosomiasis (chagas disease). Infect Dis Clin N Am. 2019;33(1):119\u201334.","journal-title":"Infect Dis Clin N Am"},{"issue":"1","key":"12231_CR10","first-page":"3","volume":"49","author":"DJ Rja","year":"2016","unstructured":"Rja DJ, Gontijo ED, Luquetti A, Shikanai-Yasuda MA, Coura JR, et al. Brazilian consensus on Chagas disease, 2015. Rev Soc Bras Med Trop. 2016, 2nd;49(1):3\u201360.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"12231_CR11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/tropicalmed5020076","volume":"5","author":"AM Hasslocher-Moreno","year":"2020","unstructured":"Hasslocher-Moreno AM, Xavier SS, Saraiva RM, Sangenis LHC, Holanda MT, Veloso HH, et al. Progression rate from the indeterminate form to the cardiac form in patients with chronic chagas disease: twenty-two-year follow-up in a Brazilian urban cohort. Trop Med Infect Dis. 2020;5(2):76.","journal-title":"Trop Med Infect Dis"},{"issue":"9723","key":"12231_CR12","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(10)60061-X","volume":"375","author":"AJ Rassi","year":"2010","unstructured":"Rassi AJ, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375(9723):1388\u2013402.","journal-title":"Lancet"},{"key":"12231_CR13","unstructured":"Pan American Health Organization. 70% of people with chagas don\u2019t know they\u2019re infected. 2021. https:\/\/www.paho.org\/en\/news\/13-4-2021-70-people-chagas-dont-know-theyre-infected. Accessed 27 Aug 2025."},{"issue":"8","key":"12231_CR14","doi-asserted-by":"publisher","first-page":"e2015072","DOI":"10.1001\/jamanetworkopen.2020.15072","volume":"3","author":"S Chadalawada","year":"2020","unstructured":"Chadalawada S, Sillau S, Archuleta S, Mundo W, Bandali M, Parra-Henao G, et al. Risk of chronic cardiomyopathy among patients with the acute phase or indeterminate form of chagas disease: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(8):e2015072.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"12231_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40506-018-0170-z","volume":"10","author":"S Meymandi","year":"2018","unstructured":"Meymandi S, Hernandez S, Park S, Sanchez DR, Forsyth C. Treatment of chagas disease in the United States. Curr Treat Options Infect Dis. 2018;10(3):373\u201388.","journal-title":"Curr Treat Options Infect Dis"},{"issue":"9","key":"12231_CR16","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/infdis\/jiab513","volume":"225","author":"CJ Forsyth","year":"2022","unstructured":"Forsyth CJ, Manne-Goehler J, Bern C, Whitman J, Hochberg NS, Edwards M, et al. Recommendations for screening and diagnosis of chagas disease in the United States. J Infect Dis. 2022;225(9):1601\u201310.","journal-title":"J Infect Dis"},{"issue":"10","key":"12231_CR17","doi-asserted-by":"publisher","first-page":"e0139363","DOI":"10.1371\/journal.pone.0139363","volume":"10","author":"Y Sguassero","year":"2015","unstructured":"Sguassero Y, Cuesta CB, Roberts KN, Hicks E, Comande D, Ciapponi A, et al. Course of chronic Trypanosoma cruzi infection after treatment based on parasitological and serological tests: a systematic review of follow-up studies. PLoS One. 2015;10(10):e0139363.","journal-title":"PLoS One"},{"key":"12231_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijid.2018.05.019","volume":"73","author":"Y Sguassero","year":"2018","unstructured":"Sguassero Y, Roberts KN, Harvey GB, Comande D, Ciapponi A, Cuesta CB, et al. Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: a systematic review and meta-analysis of individual participant data. Int J Infect Dis. 2018;73:93\u2013101.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"12231_CR19","first-page":"CD003463","volume":"2014","author":"JC Villar","year":"2014","unstructured":"Villar JC, Perez JG, Cortes OL, Riarte A, Pepper M, Marin-Neto JA, et al. Trypanocidal drugs for chronic asymptomatic trypanosoma cruzi infection. Cochrane Database Syst Rev. 2014;2014(5):CD003463.","journal-title":"Cochrane Database Syst Rev"},{"key":"12231_CR20","doi-asserted-by":"crossref","unstructured":"Vallejo M, Reyes PP, Martinez Garcia M, Gonzalez Garay AG. Trypanocidal drugs for late-stage, symptomatic chagas disease (Trypanosoma cruzi infection). Cochrane Database Syst Rev. 2020;12(12):CD004102.","DOI":"10.1002\/14651858.CD004102.pub3"},{"key":"12231_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jclinepi.2021.03.001","volume":"134","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178\u201389.","journal-title":"J Clin Epidemiol"},{"key":"12231_CR22","unstructured":"NIHR PROSPERO international prospective register of systematic reviews. 2025. https:\/\/www.crd.york.ac.uk\/PROSPERO\/login. Accessed 27 Aug 2025."},{"key":"12231_CR23","unstructured":"Language Innovations. 2025. https:\/\/www.languageinnovations.com\/. Accessed 27 Aug 2025."},{"key":"12231_CR24","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Savovi\u0107 J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: assessing risk of bias in a randomized trial. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. eds. Cochrane Handbook for systematic reviews of interventions version 6.5. Cochrane; 2019. https:\/\/training.cochrane.org\/handbook. Accessed 31 Dec 2024.","DOI":"10.1002\/9781119536604.ch8"},{"issue":"1","key":"12231_CR25","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/jrsm.1316","volume":"10","author":"D Langan","year":"2019","unstructured":"Langan D, Higgins JP, Jackson D, Bowden J, Veroniki AA, Kontopantelis E, et al. A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods. 2019;10(1):83\u201398.","journal-title":"Res Synth Methods"},{"issue":"20","key":"12231_CR26","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","volume":"370","author":"I Molina","year":"2014","unstructured":"Molina I, Gomez i Prat J, Salvador F, Trevino B, Sulleiro E, Serre N, et al. Randomized trial of posaconazole and benznidazole for chronic chagas\u2019 disease. N Engl J Med. 2014;370(20):1899\u2013908.","journal-title":"N Engl J Med"},{"key":"12231_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.actatropica.2016.09.010","volume":"164","author":"A Vallejo","year":"2016","unstructured":"Vallejo A, Monge-Maillo B, Gutierrez C, Norman FF, Lopez-Velez R, Perez-Molina JA. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate chagas disease. Acta Trop. 2016;164:117\u201324.","journal-title":"Acta Trop"},{"issue":"8","key":"12231_CR28","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jacc.2016.12.023","volume":"69","author":"CA Morillo","year":"2017","unstructured":"Morillo CA, Waskin H, Sosa-Estani S, Del Carmen Bangher M, Cuneo C, Milesi R, et al. Benznidazole and posaconazole in eliminating parasites in asymptomatic T. cruzi carriers: the STOP-CHAGAS trial. J Am Coll Cardiol. 2017;69(8):939\u201347.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"12231_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","volume":"18","author":"F Torrico","year":"2018","unstructured":"Torrico F, Gascon J, Ortiz L, Alonso-Vega C, Pinazo MJ, Schijman A, et al. Treatment of adult chronic indeterminate chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomized, placebo-controlled trial. Lancet Infect Dis. 2018;18(4):419\u201330.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"12231_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1473-3099(20)30844-6","volume":"21","author":"F Torrico","year":"2021","unstructured":"Torrico F, Gascon J, Barreira F, Blum B, Almeida IC, Alonso-Vega C, et al. New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of chagas disease (BENDITA): a phase 2, double-blind, randomised trial. Lancet Infect Dis. 2021;21(8):1129\u201340.","journal-title":"Lancet Infect Dis"},{"key":"12231_CR31","unstructured":"Fothergill P. Covidence: What is inter-rater reliability? 2024. https:\/\/www.covidence.org\/blog\/what-is-inter-rater-reliability\/. Accessed 27 Aug 2025."},{"issue":"9","key":"12231_CR32","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/sim.1761","volume":"23","author":"MJ Sweeting","year":"2004","unstructured":"Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med. 2004;23(9):1351\u201375. https:\/\/doi.org\/10.1002\/sim.1761.Erratum.in:Stat.Med.2006;25(15):2700.","journal-title":"Stat Med"},{"issue":"1","key":"12231_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/sim.2528","volume":"26","author":"MJ Bradburn","year":"2007","unstructured":"Bradburn MJ, Deeks JJ, Berlin JA, Localio AR. Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events. Stat Med. 2007;26(1):53\u201377. https:\/\/doi.org\/10.1002\/sim.2528.","journal-title":"Stat Med"},{"key":"12231_CR34","unstructured":"Jpt H, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Chapter 16.9.5, Validity of methods of meta-analysis for rare events."},{"key":"12231_CR35","unstructured":"Pan American Health Organization. Guidelines for the diagnosis and treatment of chagas disease [internet]. 2019. [cited 2025 Oct 29]. Available from: https:\/\/iris.paho.org\/handle\/10665.2\/49653. Washington, D.C.: PAHO."},{"issue":"8","key":"12231_CR36","doi-asserted-by":"publisher","first-page":"e0004792","DOI":"10.1371\/journal.pntd.0004792","volume":"10","author":"SF Breni\u00e8re","year":"2016","unstructured":"Breni\u00e8re SF, Waleckx E, Barnab\u00e9 C. Over six thousand trypanosoma cruzi strains classified into discrete typing units (DTUs): attempt at an inventory. PLoS Negl Trop Dis. 2016, Aug, 29;10(8):e0004792. https:\/\/doi.org\/10.1371\/journal.pntd.0004792. PMID: 27571035; PMCID: PMC5003346.","journal-title":"PLoS Negl Trop Dis"},{"key":"12231_CR37","doi-asserted-by":"publisher","first-page":"1342431","DOI":"10.3389\/fimmu.2024.1342431","volume":"15","author":"MMA Silvestrini","year":"2024","unstructured":"Silvestrini MMA, Alessio GD, Frias BED, Sales J\u00fanior PA, Ara\u00fajo MSS, Silvestrini CMA, Brito Alvim de Melo GE, Martins-Filho OA, Teixeira-Carvalho A, Martins HR. New insights into Trypanosoma cruzi genetic diversity, and its influence on parasite biology and clinical outcomes. Front Immunol. 2024, Apr, 9;15:1342431. https:\/\/doi.org\/10.3389\/fimmu.2024.1342431. PMID: 38655255; PMCID: PMC11035809.","journal-title":"Front Immunol"},{"issue":"6","key":"12231_CR38","doi-asserted-by":"publisher","first-page":"e0008311","DOI":"10.1371\/journal.pntd.0008311","volume":"14","author":"M Tavares de Oliveira","year":"2020","unstructured":"Tavares de Oliveira M, Sulleiro E, Silgado Gimenez A, de Lana M, Zingales B, Santana da Silva J, Marin-Neto JA, Molina I. Quantification of parasite burden of trypanosoma cruzi and identification of discrete typing units (DTUs) in blood samples of Latin American immigrants residing in Barcelona, Spain. PLoS Negl Trop Dis. 2020, Jun, 4;14(6):e0008311. https:\/\/doi.org\/10.1371\/journal.pntd.0008311. PMID: 32497037; PMCID: PMC7299330.","journal-title":"PLoS Negl Trop Dis"},{"key":"12231_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.actatropica.2016.01.032","volume":"157","author":"A Martinez-Perez","year":"2016","unstructured":"Martinez-Perez A, Poveda C, Ram\u00edrez JD, Norman F, Giron\u00e9s N, Guhl F, Monge-Maillo B, Fresno M, L\u00f3pez-V\u00e9lez R. Prevalence of Trypanosoma cruzi\u2019s discrete typing units in a cohort of Latin American migrants in Spain. Acta Trop. 2016, May;157:145\u201350. https:\/\/doi.org\/10.1016\/j.actatropica.2016.01.032. Epub 2016 Feb 2. PMID: 26851167.","journal-title":"Acta Trop"},{"key":"12231_CR40","doi-asserted-by":"publisher","first-page":"102972","DOI":"10.1016\/j.eclinm.2024.102972","volume":"79","author":"A Rassi","year":"2025","unstructured":"Rassi A, Grimshaw A, Sarwal A, Sah R, Shah S, Agudelo Higuita NI, et al. Impact of antiparasitic therapy on cardiovascular outcomes in chronic chagas disease. A systematic review and meta-analysis. EClinicalMedicine. 2025;79:102972.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"12231_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4269\/ajtmh.1998.59.526","volume":"59","author":"S Sosa Estani","year":"1998","unstructured":"Sosa Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of chagas\u2019 disease. Am J Trop Med Hyg. 1998;59(4):526\u201329.","journal-title":"Am J Trop Med Hyg"},{"issue":"14","key":"12231_CR42","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","volume":"373","author":"CA Morillo","year":"2015","unstructured":"Morillo CA, Marin-Neto JA, Avezum A, Sosa-Estani S, A R Jr, Rosas F, et al. Benefit investigators. Randomized trial of benznidazole for chronic chagas\u2019 cardiomyopathy. N Engl J Med. 2015;373(14):1295\u2013306.","journal-title":"N Engl J Med"},{"issue":"5","key":"12231_CR43","doi-asserted-by":"publisher","first-page":"e0010386","DOI":"10.1371\/journal.pntd.0010386","volume":"16","author":"C Crespillo-Andujar","year":"2022","unstructured":"Crespillo-Andujar C, Comeche B, Hamer DH, Arevalo-Rodriguez I, Alvarez-Diaz N, Zamora J, et al. Use of benznidazole to treat chronic chagas disease: an updated systematic review with a meta-analysis. PLoS Negl Trop Dis. 2022;16(5):e0010386.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"12231_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1590\/S0037-86821997000200009","volume":"30","author":"JR Coura","year":"1997","unstructured":"Coura JR, de AL, Willcox HPF, Petana W. Estudo comparativo controlado com emprego de benznidazole, nifurtimox e placebo, na forma cr\u00f4nica da doen\u00e7a de Chagas, em uma \u00e1rea de campo com transmiss\u00e3o interrompida. I. Avalia\u00e7\u00e3o preliminar. Rev Soc Bras Med Trop. 1997;30(2):139\u201344.","journal-title":"I. Avalia\u00e7\u00e3o preliminar. Rev Soc Bras Med Trop"},{"issue":"10","key":"12231_CR45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1136\/heart.89.10.1186","volume":"89","author":"AL Basquiera","year":"2003","unstructured":"Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzman S, Moreno Barral J, et al. Risk progression to chronic chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart. 2003;89(10):1186\u201390.","journal-title":"Heart"},{"issue":"6","key":"12231_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1179\/136485908X311740","volume":"102","author":"LA Benvenuti","year":"2008","unstructured":"Benvenuti LA, Roggerio A, Freitas HF, Mansur AJ, Fiorelli A, Higuchi ML. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol. 2008;102(6):481\u201387.","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"12231_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0002-8703(86)90144-4","volume":"111","author":"AC Pereira Barretto","year":"1986","unstructured":"Pereira Barretto AC, Mady C, Arteaga-Fernandez E, Stolf N, Lopes EA, Higuchi ML, et al. Right ventricular endomyocardial biopsy in chronic chagas\u2019 disease. Am Heart J. 1986;111(2):307\u201312.","journal-title":"Am Heart J"},{"issue":"3","key":"12231_CR48","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/0002-8703(87)90712-5","volume":"113","author":"HA Carrasco Guerra","year":"1987","unstructured":"Carrasco Guerra HA, Palacios-Pru E, Dagert de Scorza C, Molina C, Inglessis G, Mendoza RV. Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage. Am Heart J. 1987;113(3):716\u201324.","journal-title":"Am Heart J"},{"key":"12231_CR49","unstructured":"Villar JC, V\u00e1quiro-Herrera E, V\u00e1squez SM, Herrera VM, Olivera MJ, Ram\u00edrez JD, et al. One-year efficacy of benznidazole or nifurtimox among asymptomatic trypanosoma cruzi seropositive in Colombia: a placebo-controlled randomized trial. In: American society of tropical medicine and hygiene. ASTMH 2021 annual meeting abstract book [Internet]; 2021 Nov 17-21; virtual. Reston (va): aSTMH; 2021. Abstract nr 0455. Available from: https:\/\/www.astmh.org\/getmedia\/59a95de8-1a06-49ca-9fd0-286454cc241a\/ASTMH-2021-Annual-Meeting-Abstract-Book.pdf."},{"issue":"1","key":"12231_CR50","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s13063-020-4226-2","volume":"21","author":"D Molina-Morant","year":"2020","unstructured":"Molina-Morant D, Fernandez ML, Bosch-Nicolau P, Sulleiro E, Bangher M, Salvador F, et al. Efficacy and safety assessment of different dosage of benznidazole for the treatment of chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized phase II non-inferiority clinical trial. Trials. 2020;21(1):328.","journal-title":"Trials"},{"key":"12231_CR51","unstructured":"Riarte AR, Prado NG, de Rissio Am, Vel\u00e1zquez EB, Ram\u00edrez JC, Hern\u00e1ndez V\u00e1zquez Y, Tom\u00e1s G, L\u00f3pez SM, Fern\u00e1ndez M, Mart\u00edn Garc\u00eda M, Estevan ML, Sinagra AJ, Luna CA, Hern\u00e1ndez L, Quaglino M, Schijman AG, Ruiz AM. TRAENA: benznidazole treatment in adult patients with low-risk chronic chagas disease \u2013 a phase 3 randomized clinical trial. Dndi informative bulletin No. 6 \u2013 chagas disease platform. 2009. Available from: https:\/\/www.dndial.org\/wp-content\/uploads\/2009\/10\/informativo6_plataformachagas_eng.pdf."},{"issue":"4","key":"12231_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S1473-3099(23)00651-5","volume":"24","author":"MJ Pinazo","year":"2024","unstructured":"Pinazo MJ, Forsyth C, Losada I, Esteban ET, Garcia-Rodriguez M, Villegas ML, et al. Efficacy and safety of fexinidazole for treatment of chronic indeterminate chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial. Lancet Infect Dis. 2024;24(4):395\u2013403.","journal-title":"Lancet Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12231-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12231-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12231-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:50:40Z","timestamp":1769442640000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12231-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12231"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12231-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"154"}}